RespireRx Pharmaceuticals Inc (fka RSPI)

[enemem]

The terms do look good, but more importantly, my sense is that R&R isn't involved.
Bringing another entity with deep pockets may strengthen cor's position, since it effectively reduces the percentage of shares held by any one stakeholder. If any entity was seeking to gain control of the IP via stock accumulation, this deal is perhaps a setback.